Guillem Loren

Design and optimization of oestrogen receptor PROTACs based on 4-hydroxytamoxifen.

R. Gomis, A. Riera, X. Verdaguer, 2022, European journal of medicinal chemistry.

Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α

M. Cubillos-Rojas, A. Riera, A. Nebreda, 2023, Cancers.

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

I. Holen, R. Gomis, Adrià Caballé, 2023, Nature Cell Biology.